Back to
Rockefeller Capital Management L.P.
QNCX
Showing 2 of 6 quarters
Position history for
Rockefeller Capital Management L.P.'s holdings in QUINCE THERAPEUTICS INC
No. Rockefeller Capital Management exited its QNCX (Quince Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 169,554 shares worth $279,764. Rockefeller Capital Management first reported QNCX in Q1 2021 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$279,764
Total Shares Change
-169,554
Quarter-by-Quarter History